Background:
The conventional method of implanting balloon-expandable SAPIEN-3 (S3) valve results in a final 70:30 or 80:20 ratio of the valve in the aorta:left ventricular outflow tract with published rates of permanent pacemaker around 10%. We sought to evaluate whether higher implantation of S3 reduces conduction abnormalities including the need for permanent pacemaker.
Methods:
We included consecutive patients who underwent transfemoral transcatheter aortic valve replacement using S3 between April 2015 and December 2018 and compared outcomes with typical valve deployment strategy to our more contemporary high deployment technique (HDT). We excluded patients with nontransfemoral access or valve-in-valve.
Results:
Among 1028 patients, HDT was performed in 406 patients (39.5%). Mean implantation depth under the noncoronary cusp was significantly smaller with HDT compared with conventional technique (1.5±1.6 versus 3.2±1.9 mm;
P
<0.001). Successful implantation was achieved in 100% of the patients in both groups with no cases of conversion to open heart surgery, second valve implantation within the first transcatheter aortic valve replacement, or coronary occlusion during transcatheter aortic valve replacement. One patient (0.2%) had valve embolization with HDT (
P
=0.216). Thirty-day permanent pacemaker rates were lower with HDT (5.5% versus 13.1%;
P
<0.001), as were rates of complete heart block (3.5% versus 11.2%;
P
<0.001) and new-onset left bundle branch block (5.3% versus 12.2%;
P
<0.001). There were no differences in mild (16.5% versus 15.9%;
P
=0.804), or moderate-to-severe aortic regurgitation (1% versus 2.7%;
P
=0.081) at 1 year. HDT was associated with slightly higher 1-year mean gradients (13.1±6.2 versus 11.8±4.9 mm Hg;
P
=0.042) and peak gradients (25±11.9 versus 22.5±9 mm Hg;
P
=0.026). However, Doppler velocity index was similar (0.47±0.15 versus 0.48±0.13;
P
=0.772).
Conclusions:
Our novel technique for balloon-expandable S3 valve positioning consistently achieves higher implantation resulting in substantial reduction in conduction abnormalities and permanent pacemaker requirement after transcatheter aortic valve replacement without compromising procedural safety or valve hemodynamics. Operators should consider this as an important technique to improve patient outcomes.
TCT-526 Impact of Pre-existing Conduction Abnormalities on Permanent Pacemaker Requirement and Survival in Patients Undergoing Transcatheter Aortic Valve Replacement With Sapien-3 Valve
